Pharma exports from region up by over 60%

INDORE: Pharmaceutical exports from the region have registered a growth of over 60 per cent this year as against the previous year led by higher orders and up-gradation in firms.

According to data from Development Commissioner Special Economic Zone (SEZ), exports from pharmaceutical firms in fiscal year 2018/19 stood at Rs 3,771.54 crore, up 67.62 per cent as against Rs 2,249.93 crore in the past year.

An HR executive from a leading pharmaceutical company located in the Special Economic Zone (SEZ) said, “This year was extraordinary for us because the number of orders were high from our customers after we upgraded and passed certain international standards mandatory for exports.”

Pithampur has over 20 pharmaceutical companies and more new companies are expected to set up facilities in the region in coming years as the region has become the hub for pharmaceutical companies.

Another executive from a Pithampur based drug manufacturing unit said, “In comparison to other states, the cost of operations are economical here as companies are getting the SEZ benefits. Electricity is cheap, subsidies are there in addition to other facilities that makes the companies competitive.”

Industrialists said opportunities are huge for pharmaceutical companies in the region as the cost of operations and labour are economical. They expect exports to grow further in the next year.

Industrialists said, the contribution of small-scale drug manufacturers are negligible in exports and to promote them some additional subsidies to help them bear the up-gradation costs should be provided.

Indore has over 120 small scale medicines manufacturing units engaged in production of sanitizers, ointments, syrups and injectable with over 10 units engaged in exports contributing about Rs 500 crore annual exports.

Alok Dave, president, Association of Industries Madhya Pradesh (AIMP) said, “Subsidies and financial assistance will help in increasing exports from small-scale drug manufacturers. The government should also develop a cluster to curtail the cost of operations of small manufacturers.”

  • Related Posts

    Cancer cure must not be hostage to Big Pharma

    In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients